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Abstract: 
Apurinic/apyrimidinic endonuclease 1 (APE1), a central enzyme in the base excision repair pathway, cleaves damaged DNA in 
Mg2+ dependent reaction. Despite characterization of nine X-ray crystallographic structures of human APE1, in some cases, bound 
to various metal ions and substrate/product, the position of the metal ion and its stoichiometry for the cleavage reaction are still 
being debated. While a mutation of the active site E96Q was proposed to eliminate Mg2+ binding at the “A” site, we show 
experimentally that this mutant still requires Mg2+ at concentration similar to that for the wild type enzyme to cleave the AP site in 
DNA. Molecular dynamics simulations of the wild type APE1, E96Q and a double missense mutant E96Q + D210N indicate that 
Mg2+ placed at the A-site destabilizes the bound AP site-containing DNA. In these simulations, the H-bond chain D238-H309-AP 
site oxygen is broken and the substrate DNA is shifted away from its crystal structure position (1DE9). In contrast, simulations 
with the Mg2+ at site B or A+B sites leave the substrate DNA at the position shown in the crystal structure (1DE9). Taken together 
our MD simulations and biochemical analysis suggests that Mg2+ binding at the B site is involved in the reaction mechanism 
associated with endonuclease function of APE1. 
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Background: 
DNA is constantly damaged due to intrinsic and extrinsic 
genotoxic agents including reactive oxygen species (ROS) and 
ionizing radiation. It is estimated that as many as 103-105 base 
lesions are endogenously induced per day in a mammalian 
genome  [1,2] which include oxidized bases, single-strand 
breaks (SSBs) and apurinic/apyrimidinic (AP) sites. These 
lesions are often cytotoxic and mutagenic [3]. Hence their repair 
is imperative for maintaining genome integrity. The base 
excision repair (BER) pathway is the primary process for 
repairing AP sites in which AP endonuclease (APE1) has the 
central role [4]. APE1 hydrolyzes the phosphodiester backbone 
of the DNA 5' to the AP site and generates 3'-OH and 5'-
deoxyribose phosphate (dRP) that has to be removed before gap 
filling repair synthesis by a DNA polymerase followed by 
ligation of the nick by a DNA ligase [5].  
 
The structure and mechanism of APE1 has been studied 
extensively [6], and there are nine crystal structures available in 
the PDB-databank (Table 1, see supplemetray material). BIOINFORMATION  open access 
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Mundle  et al. [7] showed that the Mg2+-assisted cleavage is a 
one-step (concerted) reaction. One crystal structure of APE1 and 
product DNA (1DE9) has a single Mn2+ metal ion [8] at a 
position called the A site. The Mn2+ in this crystal structure is 
coordinated by the carboxyl group of E96. Five more crystal 
structures without substrate or product DNA have also one 
metal ion each (Sm3+, Pb2+, and Mg2+) at the A site [8-11] (Table 
1, see supplemetray material). Another crystal structure of free 
APE1 shows two non-catalytic metal Pb2+ i o n s  a t  p o s i t i o n s  
defined as A and B site [10]. The B site Pb2+ is close to residue 
D210 which is essential for the endonuclease activity [12, 13]. 
We showed in an earlier Molecular Dynamic (MD) simulation 
study the existence of two low potential energy sites for a single 
Mg2+ in pre-cleavage complexes of AP site-containing DNA 
substrate and APE1 [14]. These two sites were close to the A- 
and B sites. In that study we also proposed the “moving metal” 
mechanism  [14]. It is essentially the same single Mg2+ ion 
mechanism as proposed by Mol et al. [8]. The difference was the 
location of the Mg2+ in the pre-cleavage state. In the simulation 
study with the APE1-substrate DNA complex in the pre-
cleavage state, the Mg2+ ion was held most stably at the B site. It 
then moved to the A site after cleavage of the substrate DNA. 
Similar mechanisms involving movement of a catalytic metal 
ion have been suggested for other enzymes, such as for E. coli 
ribonuclease  [15] and restriction endonucleases [16]. On the 
other hand, cleavage reaction with two metal ions proposed by 
Beernink  et al. [10] assumes that the site B metal activates a 
coordinating water molecule to produce the OH- for the 
nucleophilic attack. The second metal at the site A would then 
stabilize the leaving 3’ end of the product.  
 
In a recent solid state NMR study of APE1 the authors observed 
in the first part (APE1 without the substrate DNA) two Mg2+ 
ion signals [17]. They also found in the second part (in the 
presence of substrate DNA) of that study that both the E96Q 
mutant (an A-site mutant) and the double mutant E96Q/D210N 
had equivalent Mg2+ binding, i.e. the difference spectrum for 
these two mutants was null. Their interpretation of this was that 
neither mutant was capable of binding Mg2+, and that there was 
no second binding site (B site) for Mg2+  in the active site. In the 
present study, we have confirmed that, as with the E96A 
mutant we had examined previously [18], had endonuclease 
activity in presence of Mg2+. To explore the nature of the 
binding sites, we carried out MD simulations with Mg2+  ion(s) 
placed at the A-, B or A+ B sites in pre-cleavage substrate DNA 
complexes of WT APE1, and its E96Q and E96Q/D210N 
(named ED) mutants. These simulations showed that Mg2+  at 
the A-site destabilizes the substrate DNA, while Mg2+  at B or 
A+B site leaves the substrate DNA at the position observed in 
the crystal structure (1DE8) of Mol et al. [8]. 
 
Methodology: 
Construction of WT and E96Q Mutant APE1 Polypeptides:  
The coding sequence for full-length human APE1 was inserted 
in the pET15b vector (Novagen) at NdeI/XhoI sites for 
expression of APE1 in E. coli. The source of the WT APE1 cDNA 
was described earlier [19]. The point mutation at residue 96 
from glutamic acid to glutamine (E96Q) we created by using a 
site-directed mutagenesis kit and following the manufacturer’s 
guidelines (QuickChange II XL, Agilent Technologies, Santa 
Clara, CA, USA). Briefly, APE1 cDNA was used as the template 
in PCR for generating the E96Q mutation with forward (5' 
ccagatatactgtgccttcaacagaccaaatgttcagag 3') and reverse (3' 
ggtctatatgacacggaagttgtctggtttacaagtctc 5') primers that were 
designed with the help of “The QuikChange® Primer Design 
Program” (available at http://www.genomics.agilent.com). 
The DNA sequences of the WT and mutant E96Q APE1 cDNA 
were confirmed in UTMB's Recombinant DNA Laboratory 
(RDL).  
 
Expression and Purification of WT APE1 and E96Q 
Polypeptides: 
T h e  W T  A P E 1  a n d  E 9 6 Q  m u t a n t  p r o t e i n s  w e r e  p u r i f i e d  a s  
previously described [18, 20] with slight modifications. The 
proteins possessing a C-terminal His6-tag were purified via 
immobilized metal affinity and ion-exchange chromatography. 
Briefly, the E. coli BL21 (DE3)/RIPL cells were transformed with 
the pET15b-derivatives and the bacterial culture (1L in LB 
broth) were grown to an OD600 of 0.6. Then the APE1 protein 
was induced with 0.5 mM isopropyl-ß-D-thiogalactopyranoside 
(IPTG) at 16 ºC for 14-16 h. The cells were then resuspended in a 
lysis/binding buffer containing 20 mM Tris-HCl (pH 8.0) and 
0.5 M NaCl, sonicated and centrifuged. The supernatants were 
loaded on a 3 ml column of Ni-NTA (Qiagen). After washing 
the column with 18 ml lysis/binding buffer and then with the 
same buffer containing 20 mM imidazole, the proteins were 
eluted with 10 ml lysis buffer containing 200 mM imidazole, 
and dialyzed against 20 mM Tris-Cl (pH 8.0), 100 mM NaCl, 1 
mM EDTA, 1 mM dithiotreitol (DTT) and 10% glycerol. The 
histidine tag was removed from the proteins after overnight 
incubation (16 h) with thrombin at 4 ºC, and APE1 fractions 
were further purified to homogeneity using HiTrap SP HP 
column by ion-exchange chromatography using the LCC-500 
PLUS (Pharmacia). The final fractions were dialyzed against 20 
mM Tris (pH 8.0), 150 mM NaCl, 0.1 mM EDTA, 1 mM DTT, 
and 50% glycerol, and stored at -20 ºC.  
 
AP-Endonuclease Activity and EMSA: 
A 43-mer oligo nucleotide duplex containing tetrahydrofuran 
(THF) at position 31 in the sequence 5' 
ATCTGATTCCCCATCTCCTCAGTTTCACTXCTGCACCGCA
TG 3' (X: THF) was purchased from Midland Inc. (USA) and 
prepared as described previously [18, 20, 21]. The oligo was 5'-
end-labeled with [γ-32P]ATP and T4 polynucleotide kinase 
(PNKP). After annealing to the complementary strand with C 
opposite THF, the duplex oligo was purified by gel filtration 
column (Clontech, Chroma Spin TE 10). 
 
Duplex THF-containing oligo was incubated with recombinant 
WT APE1 (0.1 nM) at 37 °C (3 min and 30 min) or E96Q mutant 
(0.1 or 1.0 nM) at 37 °C for 30 min in a 15 µl reaction mixture 
containing 50 mM Tris–HCl (pH 8), 50 mM KCl, with MgCl2 (2, 
5, and 10 mM) or without, 1 mM DTT, 0.1 mM EDTA and 100 
µg/ml bovine serum albumin. After stopping the reaction by 
adding 10 µl 80% formamide/40 mM NaOH containing 0.05% 
xylene cyanol, followed by heating at 95 ºC for 5 min and 
cooling on ice, the samples were analyzed by denaturing gel 
electrophoresis in 15% polyacrylamide containing 8 M urea to 
separate the substrate DNA from the cleaved product. Gels 
were then analyzed with a phosphorescence detection system 
(Storm, Molecular Dynamics).  
 
The radiolabel THF oligo (about 25 pM) was incubated with 0.1 
nM WT or E96Q mutant APE1 in the absence or presence of BIOINFORMATION  open access 
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Mg2+, and the protein-DNA complexes were analyzed in the 
EMSA-binding buffer containing 40 mM HEPES, 50 mM KCl, 
and 1 mM DTT for 15 min at 37 °C followed by electrophoresis 
in non-denaturing 6% polyacrylamide gel containing 7 mM 
Tris-HCl (pH 8.0), 3.3 mM sodium acetate and 1 mM EDTA at 4 
°C for 1 h at 100 V and the radioactivity in the gels were 
analyzed as described [22, 20]. 
 
MD Simulation: 
All MD simulations were performed using programs from the 
AMBER9 suite [23]. The parameters were NPT ensemble (P = 1 
bar and T = 315 K) with periodic boundary conditions and ff03 
force field parameters [24]. We constructed models for the APE1 
complexed with AP site-containing oligonucleotide and Mg2+ 
from conformations that we had generated in aforementioned 
MD simulation study [14]. In that study, we used a systematic 
grid search to determine low potential energy binding sites for 
one Mg2+ ion in APE1. These low potential energy sites were 
clustered at the A and B sites. For the current simulations with 
Mg2+ at the A or B site, we used the same A and B site low 
potential energy conformations. In the simulations with two 
Mg2+ ions, we started with the A site lowest potential energy 
conformation and superimposed on this the B site position for 
the second Mg2+. We generated single E96Q and double ED 
APE1 mutants by deleting first the side chain oxygen atoms at 
positions 96 and 210. Then we added the missing oxygen and 
NH2 atoms for these positions using the XLEAP module of the 
AMBER9 package. Same module was also used to add Na+ ions 
to achieve electrostatic neutrality. Next, we soaked the 
complexes in TIP3 water boxes [25] large enough to ensure that 
each box wall was at least 10 Å away from any complex atom. 
 
After constructing the complexes of APE1, its AP site containing 
11-mer oligo substrate, cofactor Mg2+ and the water box, we 
first energy-minimized the complexes over 2000 steps and then 
continued with MD simulation over 1 ns for single Mg2+ (A or B 
site) and 2 ns for two Mg2+ (A+B) complexes. Finally, the 
recorded trajectories were analyzed with PTRAJ from the 
AMBER package and the snapshots were visualized with the 
program MOLMOL [26]. 
 
Results: 
WT and E96Q Mutant APE1 polypeptides have endonuclease 
activity in the presence of Mg2+: 
WT APE1 and the E96Q mutant proteins purified to near 
homogeneity (Figure 1a) were tested for Mg2+ at the active site 
by measuring AP endonuclease activity. We used a 43-mer 
duplex oligo containing THF at position 31 in the standard 
assay buffer containing 2 mM Mg2+ as described in the 
Methods. While no activity was observed with 0.1 nM E96Q 
mutant, increasing the concentration by 10 times (1.0 nM) in the 
presence of 2 mM Mg2+  cleaved the substrate after 30 min 
incubation  (Figure 1b). Such Mg2+-dependent cleavage activity 
in the E96Q mutant was confirmed using two independent 
preparations of the mutant protein. We therefore concluded 
that the E96Q APE1 mutant is indeed capable of binding Mg2+. 
Both WT and E96Q mutant APE1 were able to bind the THF 
oligo in the absence of Mg2+. Addition of Mg2+ activated the WT 
enzyme resulting in the loss of the oligo bound APE1 complex. 
In contrast, the E96Q mutant APE1 remained bound to the THF 
oligo  (Figure 1c) presumably because of its slow turnover 
(Figure 1b). These results are consistent with previous results 
[20, 27, 13, 28] which showed that the E96 mutants had less 
activity than the WT enzyme but retained Mg2+-dependence for 
its activity. The highest endonuclease activity for the E96Q 
mutant was observed at 5 mM Mg2+  (Figure 1b) which was 
comparable to 8 mM Mg2+ needed for optimum activity of the 
E96A mutant we had observed earlier. Also, consistent with the 
previous study, higher Mg2+ concentration inhibited AP site-
cleavage activity [27].  
 
 
Figure 1: a) Coomassie blue staining of purified WT and E96Q 
mutant APE1 proteins (0.5 µg protein) after SDS-PAGE (10% 
polyacrylamide); lane 1, marker; lane 2, WT APE1; and lane 3, 
E96Q proteins. b) AP-endonuclease activity was measured 
using 43-mer, THF- containing oligonucleotide. WT APE1 (0.1 
nM) was incubated for 3 min at 37 ºC as shown in lanes 2, 3, and 
4 using a buffer containing 50 mM Tris-HCl (pH 8.0), 50 mM 
KCl and in absence or in presence of 2 mM Mg2+  respectively. 
The endonuclease activity of E96Q (1.0 nM) mutant APE1 was 
measured in the absence or in presence of 2, 5, and 10 mM Mg2+  
as shown in lanes 5, 6, 7, and 8 respectively for 30 min at 37 ºC. 
c) EMSA of THF-DNA binding by WT and E96Q (0.1 nM) 
mutant APE1 proteins. Lane 1, no protein; lane 2, WT APE1 
without Mg2+; lanes 3 & 4, with 5 and 10 mM Mg2+  
respectively; lane 5, no protein; lane 6, E96Q without Mg2+; 
lanes 7 & 8, with 5 and 10 mM Mg2+ respectively. While lanes, 2 
& 6 supplemented with 2 mM EDTA. The data represent three 
or more independent experiments. 
 
Mg2+ bound at the A site destabilizes substrate DNA: 
In all three simulations of WT, E96Q and ED APE1 with the 
Mg2+ bound at the A site, the substrate DNA shifted 
significantly from its starting position (Figure 2 and S2). Placing 
a Mg2+ at the A site interfered with the H-bond chain D283-
H309-AP phosphate oxygen (yellow dotted line in Figures 2-6 
and S2-S6), preventing the H-bond between H309 and the AP 
phosphate oxygen that is essential for substrate binding and BIOINFORMATION  open access 
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c l e a v a g e ,  a s  i n d i c a t e d  b y  1 3  f o l d  h i g h e r  K m  o f  t h e  H 3 0 9 N  
mutant than of WT enzyme [29, 30]. 
 
 
Figure 2: Snapshots of the A site MD-simulations after initial 
minimization (green) and after 1 ns simulation (blue). Panels on 
the left and right show global and closeup views. WT, E96Q 
and ED snapshots are shown in a, b and c. 
 
The final substrate DNA binding site was different for each 
complex in these simulations with Mg2+ at the A site (Figure 5a 
and S5a). In agreement with the crystal structure of the 
product-APE1- Mg2+ complex (PDB-code 1DE9), Mg2+ in the 
pre-cleavage DNA-APE1- Mg2+ complex was coordinated by 
E/Q96 side chains. In WT APE1 simulation, Mg2+ was 
hexagonally coordinated by both E96 side chain oxygens, one 
oxygen each from D308, D70, AP phosphate and a water 
molecule. The residues D308 and D70 are among the conserved 
residues in APE1 and related sequences [31,32]. Similarly, in 
E96Q and ED mutant simulations, Mg2+ was coordinated by 
both side chain oxygens of D308, and one oxygen each of Q96 
(instead of E96), D70, AP phosphate and a water molecule. 
However, in the 1 ns WT simulation, the AP site P-atom 
position was 4.1 Å away from its crystal structure (1DE9) 
position with the product and Mg2+ ion (Table 2, see 
supplementary material). This distance between the crystal 
structure of the substrate-DNA complex (1DE8) and the WT 
simulation was even larger (4.8 Å). Same distance of the AP site 
P-atoms between the two crystal structures [8] (1DE9 and 1DE8) 
is 1.0 Å. In agreement with this we showed in a previous study 
[20], that Mg2+ bound at the B site had pulled the substrate 
DNA by 1.0 Å toward D210.  
 
 
Figure 3: Snapshots of the B site MD-simulations after initial 
minimization (green) and after 1 ns simulation (blue). Panels on 
the left and right show global and closeup views. WT, E96Q 
and ED snapshots are shown in a, b and c. 
 
Mg2+ ion at the B site leaves the pre-cleavage substrate DNA 
close to the position observed in the crystal structure:  
Unlike for the A site simulations, placing the Mg2+ at the B site 
left the substrate DNA close to its starting crystal structure BIOINFORMATION  open access 
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position (1DE8). In the simulations of WT, E96Q and ED 
proteins, the B site Mg2+ did not shift the AP site (Figure 3 and 
S3), and the final position of the AP site in all three simulations 
were very close to one another (Figure 5b and S5b). The H-
bond chain D283-H309-AP site phosphate oxygen was intact in 
all three simulations (Figure 3, 6 and S3,S6). Furthermore, in 
contrast to the A site simulations, placing the Mg2+ at the B site 
kept the AP site P-atom close to the corresponding crystal 
structure P-atoms in the product plus Mn2+ (1DE9) and 
substrate (1DE8) containing crystal structures (0.9 Å and 1.8 Å).  
 
The B site Mg2+, contrary to the assumption of Lipton et al. [17] 
and others that E96 is only a A site ligand and therefore would 
coordinate only the A site metal ion, was coordinated also by 
the E/Q96 side chains. Similar behavior we had observed in 
earlier simulations [20,14]. We always found that the E96 side 
chain coordinated the Mg2+ ion, and followed the movement of 
the Mg2+ ion from the B to the A site. During the migration of 
the Mg2+ from the B to the A site the OE2 atom on E96 needed 
to move only 2.07 Å. Figures 6 and S6a show the active site and 
coordination of the B site Mg2+  after 1 ns WT simulation. Here 
and in the other two B site simulations the Mg2+ was 
hexagonally coordinated by the side chains of E96, N212, D210 
(both side chain oxygens), AP phosphate oxygen and a water 
molecule.  
 
 
Figure 4: Snapshots of the A+B site MD-simulations after initial 
minimization (green) and after 2 ns simulation (blue). Panels on 
the left and right show global and closeup views. WT, E96Q 
and ED snapshots are shown in a, b and c. 
 
Figure 5: Superposition of the final snapshots of the WT (green), 
E96Q (grey) and ED simulations (blue). On the left and right are 
global and closeup views shown. The simulations with one 
Mg2+ (A and B site) were run over 1 ns, while the simulations 
with two Mg2+ (A+B) were run over 2 ns. 
 
AP phosphate oxygens bridge A and B site bound Mg2+ ions 
In the MD-simulations with two Mg2+ ions bound at the A and 
B site, the Mg2+ ions were bridged by the AP site phosphate 
oxygens. Additionally, E96 in the WT simulation also bridged 
the two Mg2+ ions (Figures 4, 5c and S4, S5c). This behavior was 
different from what we observed in earlier simulations [14] 
where we started with two Mg2+ ions at the Pb2+position in 
APE1’s crystal structure 1E9N [10]. In the current simulations, 
we started with two grid search positions (low potential energy 
positions)  [14]. Earlier, the two Mg2+ i o n s  m ov e d  a w ay f r o m  
each other [14], while in these simulations they moved closer. 
They were stabilized by phosphate oxygens of the AP site and 
additionally by the E96 carboxyl group in WT APE1 simulation 
(Figure S6b). In the E96Q and ED APE1 simulations, the side 
chain oxygen of Q96 coordinated only the B site Mg2+ and could BIOINFORMATION  open access 
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not bridge both Mg2+ ions. Nevertheless, the H-bond chain 
D283-H309-AP site phosphate oxygen was intact (yellow dotted 
lines in Figures 4, 5c and S4, S5c, S6b). The distances between 
the AP site P-atom positions from the WT simulation with two 
Mg2+ (at sites A+B) to the corresponding P-atom positions in the 
crystal structures (1DE8: substrate alone and 1DE9: product 
plus Mn2+) were 2.1 Å and 1.2 Å. These distances were larger 
than the distances from the WT APE1 simulation with one Mg2+ 
ion bound at the B site to the same crystal structures (1.8 Å and 
0.9 Å) (Table 2, see supplementary material). 
 
 
Figure 6: Active site and Mg2+ coordination at the end of the 1 
ns WT simulation with AP containing DNA substrate and Mg2+ 
at the B site. 
 
Discussion: 
As noted in the introduction, the exact stoichiometry of the 
metal ion in the APE1 cleavage reaction is still being debated 
because that could only be inferred from indirect 
measurements. The most reliable way to determine the location 
of Mg2+ during catalysis is by analysis of the active site of 
crystal structures [8-11]. As we previously discussed, such data 
for APE1 indicate two different binding sites for Mg2+ (A and B 
site). Although solid-state 25Mg NMR has been proposed as a 
way to quantitate the number of metal ions bound, this method 
is still problematic, because of background due to nonspecific 
Mg2+ binding. While Lipton et al. [17] identified, in the first part 
of their study, two different Mg2+ signals originating from Mg2+ 
bound in the active site of free APE1 (no substrate-bound), they 
could not establish the positions for these two Mg2+ ions. Our 
previously described grid search data indicated that there were 
two, low potential energy positions for Mg2+ ions. These were 
close to the positions of metal ions in the crystal structures [14]. 
In our current MD-simulations with two Mg2+ ions at the A and 
B site the APE1-substrate-Mg2+ ions complex was also stable. 
Therefore, the two different Mg2+ signals from the solid state 
NMR study are consistent with both (1DE8 and 1DE9) crystal 
structures, our “moving metal” model and the two Mg2+ 
complex presented in this study. However, the rejection of the B 
site in the second part of the solid state NMR study [17] Lipton 
et al. is not justified. Logical consequence of the argumentation 
of Lipton et al. would be that neither the ED nor E96Q mutant 
would be able to bind any Mg2+ at the active site. In this study 
we showed qualitative experimental confirmation of earlier 
results from Erzberger et al. [13], Nguyen et al. [33] and Chou et 
al.  [28], that the E96Q mutant has Mg2+-dependent (low but 
detectable) endonuclease activity. Although these experiments 
did not allow the determination of the specific location of the 
Mg2+ (A or B site) on APE1, it is safe to conclude that Mg2+ was 
bound at the active site. In MD simulations for this study we 
showed that Mg2+ binding at the A site alone is very unlikely. 
Assuming that the ion does not move, this Mg2+ position would 
be consistent with the crystal structure of the APE1-cleaved 
DNA-Mn2+ complex (1DE9). However, the distance between the 
Mn2+ and D210 in this crystal structure is larger than 5.5 Å. 
Therefore, this crystal structure cannot explain the complete 
loss of endonuclease activity in D210 mutants [12, 13]. This is 
also the weakness of the one Mg2+ mechanism that shows the 
Mg2+ bound at the A site [8]. Additionally, placing only one 
Mg2+ at the A site destabilized the substrate in the MD 
simulations. It also interfered with the H-bond chain D283-
H309-AP site, which is critical for substrate binding [29, 30]. 
Placing the Mg2+ at the B site on the other hand kept the 
substrate DNA stable at its crystal structure position and the H-
bond chain D283-H309-AP site phosphate intact. The B site 
Mg2+ was coordinated by D210, which explains the essential 
role of D210 for the endonuclease activity. Further, B site Mg2+ 
shifted the AP site of the substrate closer to D210 and closer to 
the AP site position in the crystal structure with the product 
(1DE9). Assuming that Mg2+ is bound at the B site prior to 
cleavage, it has to move to the A site after cleavage in order to 
be consistent with the APE1-product-Mn2+ crystal structure 
(1DE9). This is essentially our “moving metal” mechanism [14] 
based on MD simulations. As shown in Figure 6 and S6a, the B 
site Mg2+ was coordinated pre-cleavage by E96, D210, N212, 
AP-phosphate and a water molecule. In our mechanism D210 
accepts the proton during the activation process of the Mg2+ 
bound water molecule to create the nucleophile OH-. In that 
process the acquired proton weakens the D210-Mg2+ interaction 
and repels the Mg2+ that then moves to the A site. N212 has 
been shown to be involved in substrate binding [34], which 
could also be explained in our model. N212 coordinated the 
Mg2+ and forms a H-bond with the substrate. E96 is located 
between the A and B site enabling it to coordinate the Mg2+ at 
both sites. In all simulations we observed that it was 
coordinating a Mg2+ independent of where the Mg2+ was 
located. In our current MD-simulations with two Mg2+ ions at 
the A+B site the important H-bond chain D283-H309-AP site 
also remained intact. The AP site phosphate oxygens and the 
E96 side chain oxygens bridged the Mg2+ ions (Figure S6b) and 
left the substrate relatively stable. However, the AP site 
positions in the single B site Mg2+ simulations were closer to the 
crystal structure positions (1DE8 and 1DE9) than the AP site 
position in the simulations with two Mg2+ ions at the A+B sites. 
Additionally, in the crystal structure with the product bound 
(1DE9), there is only one Mn2+ ion. In our MD-simulations we 
started with conformations close to the global minimum, 
namely the crystal structure 1DE8. Therefore, in general one 
would expect small conformational changes that represent only 
local rearrangements and fluctuations around this minimum. 
We saw this kind of fluctuations with the B and A+B site 
simulations. The A site simulation on the other hand showed 
even at the end of our relatively short simulation time large 
changes compared with the initial conformation. This indicates BIOINFORMATION  open access 
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that placing one Mg2+ ion at A site did change the energy 
landscape drastically. Accordingly, longer simulation would 
show only even larger conformational changes. Finally, we 
predict that solving the crystallographic structure of Mg2+ 
bound to the D210N mutant will unequivocally establish the 
pre-cleavage position and number of Mg2+ ion(s). Because the 
D210N mutation renders APE1 totally inactive, the Mg2+ ion(s) 
would be trapped in their pre-cleavage position(s), which 
should be evident in the protein structure. 
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Supplementary material: 
 
Table 1: Crystal structures of APE1 
PDB-code   Resolution  Metal ions  Substrate/Product DNA 
1DE8a  2.9Å  ---  Not cleaved substrate with one AP site (11 bp) 
1DEWa  2.7Å  ---  Not cleaved substrate with one AP site (15 bp) 
1DE9a  3.0Å Mn2+ (at the active site)  Cleaved product 5’ to the AP site (9 bp) 
1BIXb  2.2Å 4  Sm3+, 1 Pt2+ (one Sm3+ at the active site)  --- 
1HD7c  2.0Å Pb2+ (at the active site)  --- 
1E9Nc  2.2Å 2  Pb2+ (both at the active site)  --- 
2O3Hd  1.9Å 2  Sm3+ (one at the active site)  --- 
2O3Cd 2.3  Å 3  Pb2+ (one at the active site)  --- 
2ISIe 2.8  Å 1  Mg2+ (at the active site)  --- 
aMol et al. 2000 [8] 
bGorman et al. 1997 [9]  
cBeernink et al. 2001 [10] 
dGeorgiadis et al. 2008 [11] 
eReference not available 
 
Table 2: Effect of the Mg2+ position on the AP site P-atom distances (Å) 
   WT APE1 
MD-simulations 
Crystal Structures 
   A B A+B  1DE8  1DE9  (A) 
WT APE1 
MD-simulations 
A  --- 4.1  4.0  4.8 4.1 
B  4.1 ---  0.7  1.8 0.9 
A+B  4.0 0.7 ---  2.1 1.2 
Crystal Structures 
1DE8  4.8 1.8 2.1  ---  1.0 
1DE9 (A)  4.1 0.9 1.2  1.0  --- 
 
 
Supplementary figures: 
 
 
Figure S2a: Stereo view of the snapshots of the WT A site MD-simulationafter initial minimization (green) and after 1 ns simulation 
(blue).  
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Figure S2b: Stereo view of the snapshots of the E96Q mutant Asite MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
 
 
Figure S2c: Stereo view of the snapshots of the ED mutant A site MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
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Figure S3a: Stereo view of the snapshots of the WT B site MD-simulationafter initial minimization (green) and after 1 ns simulation 
(blue).  
 
 
Figure S3b: Stereo view of the snapshots of the E96Q mutant B site MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
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Figure S3c: Stereo view of the snapshots of the ED mutant B site MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
 
 
Figure S4a: Stereo view of the snapshots of the WT AB site MD-simulationafter initial minimization (green) and after 1  ns 
simulation (blue).  
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Figure S4b: Stereo view of the snapshots of the E96Q mutant AB site MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
 
 
Figure S4c: Stereo view of the snapshots of the ED mutant AB site MD-simulationafter initial minimization (green) and after 1 ns 
simulation (blue).  
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Figure S5a: Superposition of the 1 nssnapshots of the A site simulations of WT (green), E96Q (grey) and ED simulations (blue).  
 
 
Figure S5b: Superposition of the 1nssnapshots of the B site simulations of WT (green), E96Q (grey) and ED simulations (blue).  
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Figure S5c: Superposition of the 2 ns snapshots of the A+B site simulations of WT (green), E96Q (grey) and ED simulations (blue).  
 
 
Figure S6a:Stereoview of the active site and Mg2+ coordination at the end of the 1 ns WT simulation with AP containing DNA 
substrate and Mg2+at the B site. 
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Figure S6b:Stereoview of the active site and the 2 Mg2+ions coordination at the end of the 2 ns WT simulation with AP containing 
DNA substrate and 2 Mg2+ions at the A+B site. 